Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis

Bryan E. Shepherd*, Cathy A. Jenkins, Deidra D. Parrish, Tracy R. Glass, Angela Cescon, Angels Masabeu, Genevieve Chene, Frank De Wolf, Heidi M. Crane, Inma Jarrin, John Gill, Julia Del Amo, Sophie Abgrall, Pavel Khaykin, Clara Lehmann, Suzanne M. Ingle, Margaret T. May, Jonathan A C Sterne, Timothy R. Sterling

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

12 Citations (Scopus)

Abstract

In lower-income countries rates of AIDS-defining events (ADEs) and death are high during the first year of combination antiretroviral therapy (ART). We investigated differences between foreign-born (migrant) and native-born (nonmigrant) patients initiating ART in Europe, the US and Canada, and examined rates of the most common ADEs and mortality during the first year of ART.
Original languageEnglish
Pages (from-to)1321-1329
Number of pages9
JournalAIDS
Volume27
Issue number8
DOIs
Publication statusPublished - 15 May 2013

Keywords

  • AIDS
  • Antiretroviral therapy
  • HIV
  • Migrant
  • Mortality
  • Tuberculosis

Cite this